HomeNewsIndiaADB lends record $4.6 billion loans to India in 2021

ADB lends record $4.6 billion loans to India in 2021

Of the COVID-19-related assistance, $1.5 billion was towards vaccine procurement and $300 million to strengthen primary health care in urban areas and the country's future pandemic preparedness.

February 06, 2022 / 16:43 IST
Representative Image of children receiving COVID-19 vaccine (Image: ANI)

The Asian Development Bank (ADB) on Sunday said it provided a record $4.6 billion loans to India in 2021, including $1.8 billion towards coronavirus response. "The Asian Development Bank committed a record $4.6 billion in sovereign lending to India in 2021 for 17 loans, including $1.8 billion for the country's coronavirus disease (COVID-19) pandemic response," the multilateral funding agency said in a statement.

Of the COVID-19-related assistance, $1.5 billion was towards vaccine procurement and $300 million to strengthen primary health care in urban areas and the country's future pandemic preparedness. The ADB's regular funding programme to India is made to support transport, urban development, finance, agriculture, and skills building.

ALSO READ: ADB to develop blockchain network prototype for central banks' cross-border securities transactions

ADB Country Director for India Takeo Konishi said, "The ADB's operations continue to support the Government of India's fight against COVID-19 and its other development priorities such as managing urbanisation, raising industrial competitiveness to create more jobs, improving connectivity and enhancing skills." Konishi added that to maximise the development impact of its operations, ADB adopts a multidisciplinary approach and incorporates Finance Plus elements based on its comparative advantage, knowledge base and value addition.

He said the ADB will continue to support less-developed states through the provision of basic infrastructure and institutional capacity building while pursuing transformative investments in the more economically advanced states. The agency extended a $2.2-billion support for 12 state projects, committed to its geographically balanced programming.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The funding body said its strategic engagement with states will include knowledge support to navigate their emerging development challenges. The ADB's project portfolio in 2021 reflected the Indian government's focus on transforming cities into economically vibrant and sustainable communities.

This included financing for India's national urban flagship missions to enhance access to water, sanitation, and affordable housing and promote performance-based fiscal transfer to urban local bodies; enhancing mobility through metro network expansion in Bengaluru; and strengthening flood-risk management in Chennai's urban areas. Support to the government's National Industrial Corridor Development Programme will help enhance the country's manufacturing competitiveness while a connectivity improvement project will stimulate industrial development in the ADB-supported Chennai-Kanyakumari Industrial Corridor.

Other projects fund rural connectivity improvement, agribusiness network development, the establishment of a skills university to promote industry-aligned skills, and capacity building for project design, the ADB said. The ADB's India portfolio comprised 69 projects worth $15.5 billion as of December 31, 2021.

In addition to sovereign loans, the ADB also committed $274 million to private sector projects in 2021 for COVID-19 support, highways improvement, energy efficiency, affordable housing and increasing farmer incomes. Going forward, Konishi said the ADB will assist India's fast, green and inclusive economic recovery from the pandemic with expanded investments in health and education; micro, small, and medium-sized enterprises; public sector management and climate initiatives.

PTI
first published: Feb 6, 2022 04:43 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347